Clinical significance of lymph node micrometastases in cervical cancer;Kliniczne znaczenie mikroprzerzutów w wȩzłach chłonnych w raku szyjki macicy

Ginekologia Polska

Volumn 84, Issue 9, 2013, Pages 788-793

  Sniadecki, Marcin ^a   Sawicki, Sambor ^a   Wojtylak, Szymon ^a   Liro, Marcin ^a   Wydra, Dariusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cervical cancer; Factor predict; Lymph nodes; Micrometastates

Indexed keywords

EID: 84888340533     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: 10.17772/gp/1641     Document Type: Article

References (44)

1. Cabanas R. An approach for the treatment of penile carcinoma. Cancer. 1977, 39, 456-466.
2. Van Akkoi A, Nowecki Z, Voit C, [et al.]. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg. 2008, 248, 949-955.
3. Stitzenberg K, Meyer A, Stern S, [et al.]. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg. 2003, 237, 607-613.
4. Dewar D, Newell B, Green M, [et al.]. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol. 2004, 22, 3345-3349.
5. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer. 1990, 65, 1923-1927.
6. Tinga D, Timmer P, Bouma J, [et al.]. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol. 1990, 39, 175-180.
7. Gould E, Winship T, Philbin P, [et al.]. Observations on a sentinel node in cancer of the parotid. Cancer. 1960, 13, 77-78.
8. Veronesi U, Paganelli G, Galimberti V, [et al.]. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997, 349, 1864-1867.
9. Morton D, Wen D, Wong J, [et al.]. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992, 127, 392-399.
10. Barranger E, Grahek D, Cortez A, [et al.]. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer. 2003, 97, 3003-3009.
11. Bats A, Clement D, Larousserie F, [et al.]. Sentinel lymph node biopsy improves staging in early cervical cancer. Gynecol Oncol. 2007, 189-193.
12. Sawicki S, Kobierski J, Cytawa W, [et al.]. Sentinel lymph node detection with the use of SPECTCT in endometrial cancer - analysis of two cases. Ginekol Pol. 2012, 83, 703-707.
13. Ichikura T, Morita D, Uchida T, [et al.]. Sentinel node concept in gastric carcinoma. World J Surg. 2002, 26, 318-322.
14. Morrow C, Shingleton H, Austin J, [et al.]. Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy?: A report from the presidential panel at the 1979 Annual Meeting of the Society of Gynecologic Oncologists. Gynecol Oncol. 1980, 10, 105-110.
15. Alvarez R, Soong S, Kinney W, [et al.]. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol. 1989, 35, 130-135.
16. Cheng X, Cai S, Li Z, [et al.]. The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery. World J Surg Oncol. 2004, 2, 47-54.
17. Garg G, Shah J, Toy E, [et al.]. Intra-operative detection of nodal metastasis in early stage cervical cancer: a survey of the practice patterns of SGO members. Gynecol Oncol. 2011, 121, 143-147.
18. Cochran A. Prediction of outcome for patients with cutaneous melanoma. Pigment Cell Res. 1997, 10, 162-167.
19. Daraï E, Rouzier R, Ballester M, [et al.]. Sentinel lymph node biopsy in gynaecological cancers: the importance of micrometastases in cervical cancer. Surg Oncol. 2008, 17, 227-235.
20. Schwartz G, Giuliano A, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. April 19-22, 2001. Philadelphia. Pennsylvania. Breast J. 2002, 8, 124-138.
21. Cibula D, Abu-Rustum N, Dusek L, [et al.]. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol. 2012, 124, 496-501.
22. Straver M, Meijnen P, van Tienhoven G, [et al.]. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol. 2010, 17, 1854- 1861.
23. Giuliano A, McCall L, Beitsch P, [et al.]. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010, 252, 426-432.
24. Bats A, Mathevet P, Buenerd A, [et al.]. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol. 2013, 20, 413-422.
25. Cibua D, Abu-Rustum NR, Dusek L, [et al.]. Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastases. Gynecol Oncol. 2012, 127, 462-466.
26. Slama J, Dundr P, Dusek L, [et al.]. Sentinel lymph node status in patients with locally advanced cervical cancers and impact on neoadjuvant chemotherapy. Gynecol Oncol. 2012, 125, 303- 306.
27. Rossi P, Horowitz I, Johnstone P, [et al.]. Lymphadenectomy for patients with cervical cancer: is it of value? J Surg Oncol. 2009, 100, 404-406.
28. Slama J, Dundr P, Dusek L, [et al.]. High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol. 2013, 129, 384-388.
29. Pearlman N, McCarter M, Frank M, [et al.]. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg. 2006, 192, 878-881.
30. Frankel T, Griffith K, Lowe L, [et al.]. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Ann Surg Oncol. 2008, 15, 2403-2411.
31. Juretzka M, Jensen K, Longacre T, [et al.]. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis. Gynecol Oncol. 2004, 93, 107-111.
32. Horn L, Hentschel B, Fiecher U, [et al.]. Detection of micrometastasis in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: frequency, topographic distribution and prognostic impact. Gynecol Oncol. 2008, 111, 276-281.
33. Pal A, Provenziano E, Duffy S, [et al.]. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. British J Surg. 2008, 95, 302-309.
34. Mittendorf E, Kelly K, Boughey J, [et al.]. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg. 2012, 255, 109-115.
35. Malur S, Krause N, Kohler C, [et al.]. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol. 2001, 80, 254-257.
36. Marnitz S, Kohler C, Bongardt S, [et al.]. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol. 2006, 103, 35-44.
37. Levenback C, Coleman R, Burke T, [et al.]. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002, 20, 688-693.
38. Wydra D, Sawicki S, Wojtylak S, [et al.]. Sentinel node identification in cervical cancer patients undergoing transperitoneal radical hysterectomy: a study of 100 cases. Int J Gynecol Cancer. 2006, 16, 649-654.
39. Bochenek A. Uklad naczyn chlonnych. W: Anatomia czlowieka. Red. Lasinski W. Warszawa: Wydawnictwo Lekarskie PZWL. 2009, 474-479.
40. Ouldamer L, Marret H, Acker O, [et al.]. Unusual localizations of sentinel lymph nodes in early stage cervical cancer. Surg Oncol. 2012, 21, e153-e157.
41. Kato H, Todo Y, Minobe S, [et al.]. Previous conisation on patient eligibility of sentinel lymph node detection for early invasive cervical cancer. Int J Gynecol Cancer. 2011, 21, 1491-1494.
42. Cibula D, Kuzel D, Slama J, [et al.]. Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer. Gynecol Oncol. 2009, 115, 46-50.
43. Li D, Cai J, Kuang Y, [et al.]. Surgical-pathologic risk factors of pelvic lymph node metastasis in stage Ib1-IIb cervical cancer. Acta Obstet Gynecol Scand. 2012, 91, 802-809.
44. Chereau E, Feron J, Ballester M, [et al.]. Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer. Br J Cancer. 2012, 106, 39-44.